• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Update on pediatric dystonias: etiology, epidemiology, and management.小儿肌张力障碍的最新进展:病因、流行病学及管理
Degener Neurol Neuromuscul Dis. 2012 Apr 11;2:29-41. doi: 10.2147/DNND.S16082. eCollection 2012.
2
Chapter 33: the history of movement disorders.第33章:运动障碍病史。
Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7.
3
Nonprimary dystonias.非原发性肌张力障碍
Handb Clin Neurol. 2011;100:513-38. doi: 10.1016/B978-0-444-52014-2.00038-0.
4
[The study and treatment of dystonias in childhood].[儿童肌张力障碍的研究与治疗]
Rev Neurol. 2006 Oct 10;43 Suppl 1:S161-8.
5
Clinical phenomenology of dystonia.肌张力障碍的临床现象学。
Int Rev Neurobiol. 2011;98:509-24. doi: 10.1016/B978-0-12-381328-2.00018-3.
6
Adult-onset dystonia.成人起病性肌张力障碍
Handb Clin Neurol. 2011;100:481-511. doi: 10.1016/B978-0-444-52014-2.00037-9.
7
The Dystonias.《肌张力障碍》
Continuum (Minneap Minn). 2022 Oct 1;28(5):1435-1475. doi: 10.1212/CON.0000000000001159.
8
Deep Brain Stimulation for Dystonia.用于治疗肌张力障碍的深部脑刺激术
Curr Treat Options Neurol. 2005 May;7(3):237-243. doi: 10.1007/s11940-005-0017-z.
9
Task-specific dystonias: a review.特定任务性肌张力障碍:综述
Ann N Y Acad Sci. 2008 Oct;1142:179-99. doi: 10.1196/annals.1444.012.
10
Classification and genetics of dystonia.肌张力障碍的分类与遗传学
Lancet Neurol. 2002 Sep;1(5):316-25. doi: 10.1016/s1474-4422(02)00137-0.

引用本文的文献

1
Local Field Potential-Based Programming for Deep Brain Stimulation in Pediatric DYT1 Dystonia.基于局部场电位的小儿DYT1肌张力障碍脑深部电刺激编程
Mov Disord Clin Pract. 2025 Feb;12(2):249-252. doi: 10.1002/mdc3.14283. Epub 2024 Dec 3.
2
A Systematic Review of Botulinum Toxin Injection in Pediatric Dystonia.肉毒毒素注射治疗小儿脑瘫的系统评价
Toxins (Basel). 2024 Jun 26;16(7):289. doi: 10.3390/toxins16070289.
3
Cerebellar dysfunction in rodent models with dystonia, tremor, and ataxia.患有肌张力障碍、震颤和共济失调的啮齿动物模型中的小脑功能障碍。
Dystonia. 2023;2. doi: 10.3389/dyst.2023.11515. Epub 2023 Dec 8.
4
The use of sertraline to treat an adolescent of dystonia comorbid with major depressive disorder with psychotic features.使用舍曲林治疗一名患有伴有精神病性特征的重度抑郁症合并肌张力障碍的青少年。
Neuropsychopharmacol Rep. 2024 Mar;44(1):275-279. doi: 10.1002/npr2.12401. Epub 2023 Nov 20.
5
Anesthetic nuances in Segawa's syndrome: A case report and review of the literature.司格威氏综合征的麻醉细微差别:一例病例报告及文献综述
Saudi J Anaesth. 2020 Oct-Dec;14(4):524-527. doi: 10.4103/sja.SJA_809_19. Epub 2020 Sep 24.
6
Abnormal cerebellar function and tremor in a mouse model for non-manifesting partially penetrant dystonia type 6.非显性部分穿透性 6 型肌张力障碍小鼠模型中的小脑功能异常和震颤。
J Physiol. 2021 Apr;599(7):2037-2054. doi: 10.1113/JP280978. Epub 2021 Jan 9.
7
Challenging neurological symptoms in paediatric palliative care: An approach to symptom evaluation and management in children with neurological impairment.儿科姑息治疗中的挑战性神经症状:神经功能受损儿童症状评估与管理方法
Paediatr Child Health. 2015 Apr;20(3):159-65. doi: 10.1093/pch/20.3.159.

本文引用的文献

1
Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.基因 PRRT2 的突变会导致阵发性运动诱发性运动障碍伴婴儿痉挛。
Cell Rep. 2012 Jan 26;1(1):2-12. doi: 10.1016/j.celrep.2011.11.001. Epub 2011 Dec 15.
2
Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias.PRRT2 基因被鉴定为发作性运动诱发性运动障碍的致病基因。
Brain. 2011 Dec;134(Pt 12):3493-3501. doi: 10.1093/brain/awr289. Epub 2011 Nov 26.
3
DYT6 dystonia: review of the literature and creation of the UMD Locus-Specific Database (LSDB) for mutations in the THAP1 gene.DYT6 型肌张力障碍:文献回顾及 THAP1 基因突变的 UMD 特异性基因座数据库(LSDB)的建立。
Hum Mutat. 2011 Nov;32(11):1213-24. doi: 10.1002/humu.21564. Epub 2011 Sep 15.
4
Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study.遗传性多巴胺转运体缺陷综合征的临床和分子特征:观察性队列和实验研究。
Lancet Neurol. 2011 Jan;10(1):54-62. doi: 10.1016/S1474-4422(10)70269-6. Epub 2010 Nov 25.
5
CSN complex controls the stability of selected synaptic proteins via a torsinA-dependent process.CSN 复合物通过依赖于 torsinA 的过程控制选定的突触蛋白的稳定性。
EMBO J. 2011 Jan 5;30(1):181-93. doi: 10.1038/emboj.2010.285. Epub 2010 Nov 19.
6
Advances in the genetics of primary torsion dystonia.原发性扭转性肌张力障碍的遗传学进展。
F1000 Biol Rep. 2010 Jun 16;2:41. doi: 10.3410/B2-41.
7
Direct interaction between causative genes of DYT1 and DYT6 primary dystonia.原发性肌张力障碍的 DYT1 和 DYT6 致病基因的直接相互作用。
Ann Neurol. 2010 Oct;68(4):549-53. doi: 10.1002/ana.22138.
8
Therapeutic challenges in dystonia.肌张力障碍的治疗挑战。
Neurol Clin. 2010 Nov;28(4):927-40. doi: 10.1016/j.ncl.2010.03.020. Epub 2010 Jul 14.
9
Pallidal and thalamic deep brain stimulation in myoclonus-dystonia.苍白球和丘脑深部脑刺激治疗肌阵挛-肌张力障碍。
Mov Disord. 2010 Aug 15;25(11):1733-43. doi: 10.1002/mds.23312.
10
Deep brain stimulation for dystonia: patient selection and outcomes.深部脑刺激治疗肌张力障碍:患者选择和结果。
Eur J Neurol. 2010 Jul;17 Suppl 1:102-6. doi: 10.1111/j.1468-1331.2010.03060.x.

小儿肌张力障碍的最新进展:病因、流行病学及管理

Update on pediatric dystonias: etiology, epidemiology, and management.

作者信息

Fernández-Alvarez Emilio, Nardocci Nardo

机构信息

Neuropediatric Department, Hospital San Juan de Dios, Barcelona, Spain,

Child Neurology Department, Fondazione IRCCS Istituto Neurologico "C. Besta", Milano, Italy.

出版信息

Degener Neurol Neuromuscul Dis. 2012 Apr 11;2:29-41. doi: 10.2147/DNND.S16082. eCollection 2012.

DOI:10.2147/DNND.S16082
PMID:30890876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6065605/
Abstract

UNLABELLED

Dystonia is a movement disorder characterized by sustained muscle contractions producing twisting, repetitive, and patterned movements or abnormal postures. Dystonia is among the most commonly observed movement disorders in clinical practice both in adults and children. It is classified on the basis of etiology, age at onset of symptoms, and distribution of affected body regions.

ETIOLOGY

The etiology of pediatric dystonia is quite heterogeneous. There are many different genetic syndromes and several causes of symptomatic syndromes. Dystonia can be secondary to virtually any pathological process that affects the motor system, and particularly the basal ganglia.

CLASSIFICATION

The etiological classification distinguishes primary dystonia with no identifiable exogenous cause or evidence of neurodegeneration and secondary syndromes.

TREATMENT

Treatment for most forms of dystonia is symptomatic and includes drugs (systemic or focal treatments, such as botulinum toxin) and surgical procedures. There are several medications including anticholinergic, dopamine-blocking and depleting agents, baclofen, and benzodiazepines. In patients with dopamine synthesis defects L-dopa treatment may be very useful. Botulinum toxin treatment may be helpful in controlling the most disabling symptoms of segmental or focal dystonia. Long-term electrical stimulation of the globus pallidum internum appears to be especially successful in children suffering from generalized dystonia.

摘要

未标注

肌张力障碍是一种运动障碍,其特征为肌肉持续收缩,产生扭曲、重复且有模式的运动或异常姿势。肌张力障碍是临床实践中成人和儿童最常见的运动障碍之一。它根据病因、症状出现的年龄以及受影响身体部位的分布进行分类。

病因

小儿肌张力障碍的病因非常多样。存在许多不同的遗传综合征以及多种症状性综合征的病因。肌张力障碍实际上可继发于任何影响运动系统,尤其是基底神经节的病理过程。

分类

病因分类区分无明确外源性病因或神经退行性变证据的原发性肌张力障碍和继发性综合征。

治疗

大多数形式的肌张力障碍治疗为对症治疗,包括药物(全身或局部治疗,如肉毒杆菌毒素)和手术程序。有多种药物,包括抗胆碱能药、多巴胺阻断和耗竭剂、巴氯芬和苯二氮䓬类药物。对于多巴胺合成缺陷的患者,左旋多巴治疗可能非常有用。肉毒杆菌毒素治疗可能有助于控制节段性或局灶性肌张力障碍最致残的症状。对苍白球内侧部进行长期电刺激似乎对患有全身性肌张力障碍的儿童特别有效。